Sema Yilmaz

36 anni di esperienza
accreditamenti:
Località: Turchia, Ankara
Clinica:Private Koru Ankara Hospital
Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation
Mostra di più

Visita dal medico

Prezzo su richiesta

Bookimed Insights: Principali specialisti in Tumore di Wilms (Nefroblastoma) in Turchia (2026)

Bookimed ha coordinato 2 richieste di trattamento per Tumore di Wilms (Nefroblastoma) in Turchia, collaborando con 1 specialisti di alto livello. I medici in questa tabella sono selezionati in base alle loro credenziali internazionali, esperienza clinica e risultati dei pazienti. La classifica del 2026 è composta da dati verificati su casi reali e dai programmi attuali delle nostre cliniche partner.

Classifica	Medico	esperienza	Buona scelta per	Cosa li distingue	Clinica e posizione	Consulto

FAQ

Queste domande frequenti provengono da pazienti reali che cercano assistenza medica tramite Bookimed. Le risposte sono fornite da coordinatori medici esperti e rappresentanti affidabili delle cliniche.

Who are some highly-rated doctors in Turkey for pediatric oncology and Wilms tumor?

Highly-rated specialists for Wilms tumor in Turkey include Dr. Ceyhun Bozkurt and Dr. Ahmet Nadir Tosyali, who offer expertise in pediatric oncology and specialized surgical care. These experts hold credentials from institutions like Harvard and maintain certifications in pediatric surgical oncology and hematology.

Surgical expertise. Dr. Ahmet Nadir Tosyali at Anadolu performs complex surgeries for pediatric kidney tumors.
Harvard-trained specialist. Dr. Ceyhun Bozkurt heads the pediatric clinic at Medical Park Bahcelievler in Istanbul.
Academic leadership. Professor Hilmi Apak has 30+ years of experience focusing on childhood cancer treatments.
Advanced research. Dr. Sema Yilmaz at Koru Ankara Hospital researches cell therapies for childhood cancers.

Bookimed Expert Insight: Patients seeking treatment for Wilms tumor in Turkey benefit from an integrated approach where pediatric surgeons and oncologists, such as those at Anadolu Medical Center, coordinate closely. This center's affiliation with Johns Hopkins Medicine means treatment protocols for kidney cancers follow globally recognized standards while remaining accessible for international families.

Patient Consensus: Families appreciate that major hospitals in Istanbul can start treatment within days, offering rapid transitions from diagnosis to surgery. The presence of multilingual support staff helps parents understand the process without needing to manage language barriers or logistics themselves.

Which Turkish hospitals have the most popular clinics for Wilms tumor treatment?

Anadolu Medical Center and Memorial Sisli are among the most popular Turkish hospitals for Wilms tumor treatment. These centers hold JCI accreditation and provide multidisciplinary care. They feature specialists with international training from institutions like Johns Hopkins and Rambam Medical Center.

International affiliation. Anadolu Medical Center works with Johns Hopkins Medicine, bringing US healthcare standards to Istanbul.
Expert specialists. Prof. Dr. Yesim Yildirim at Anadolu is an ESMO-certified oncologist specializing in targeted therapies.
Academic leadership. Top doctors often serve as professors, ensuring your child receives research-backed treatment protocols.
Advanced technology. Clinics use precise tools like the TrueBeam STx to target tumors while protecting healthy tissue.

Bookimed Expert Insight: Patients often choose Anadolu Medical Center because it holds the OECI accreditation. This certificate is only given to centers that meet strict European standards for cancer care quality. Many top doctors here, such as Prof. Dr. Yesim Yildirim, have published 80+ scientific studies. This academic depth is vital for treating complex pediatric cases like nephroblastoma.

Patient Consensus: Parents often mention feeling a sense of relief after meeting the multidisciplinary teams in Istanbul. They noticed how specialists explain every step of the treatment plan clearly in English. Many were surprised by the child-friendly hospital environments that help reduce stress during chemotherapy.

What treatment protocol do Turkish doctors typically follow for Wilms tumor?

Turkish pediatric oncologists follow the SIOP protocol for Wilms tumor, often starting with preoperative chemotherapy to shrink the tumor. Specialists like Dr. Ceyhun Bozkurt and Dr. Hilmi Apak perform nephrectomy, which is a surgery to remove the kidney, and administer vincristine-based drug regimens.

Surgical resection. Surgeons perform total nephrectomy or kidney-sparing surgery to remove the cancerous mass.
Neoadjuvant chemotherapy. Doctors usually provide several weeks of upfront chemotherapy to make surgery safer.
Adjuvant therapy. Specialists use post-operative radiotherapy or intensified chemotherapy for advanced stage III–IV cases.
Multi-drug regimens. Standard protocols include combinations of vincristine, actinomycin-D, and doxorubicin to target cancer cells.

Bookimed Expert Insight: Turkish specialists emphasize integrated care by holding dual certifications in surgery and oncology. Dr. Ahmet Nadir Tosyali at Anadolu Medical Center is trained in both fields, which eliminates the need for external coordination between surgical and medical teams during complex tumor resections.

Patient Consensus: Parents noticed that chemotherapy often begins for several weeks before the surgery happens. Many mention that frequent blood draws are necessary throughout the process and suggest using ginger to help with nausea after treatments.

How do Turkish specialists manage drug shortages for Wilms tumor therapy?

Turkish specialists manage Wilms tumor drug shortages by substituting unavailable medicines like actinomycin-D with carboplatin to maintain a 90% survival rate. Experts like Dr. Hilmi Apak and Dr. Ceyhun Bozkurt utilize international sourcing and compassionate use programs to provide unregistered life-saving treatments for children.

Clinical substitution. Specialists use carboplatin to replace actinomycin-D without reducing the high patient survival rates.
Compassionate use. Doctors provide free, unapproved treatments when standard options are unavailable or have failed.
Administrative leadership. Prof. Dr. Yesim Yildirim uses healthcare management expertise to coordinate drug inventory effectively.
Precise dosing. Care teams focus on waste reduction and prioritizing doses for children with urgent needs.

Bookimed Expert Insight: Turkish oncology leaders at centers like Anadolu combine academic research with administrative MBA training to navigate supply logistics. For instance, Dr. Hilmi Apak and Prof. Dr. Yesim Yildirim hold leadership roles that allow them to integrate international research with local inventory management. This dual focus helps them secure imported therapies from EU markets while maintaining research-backed alternative clinical protocols.

Patient Consensus: Patients are often relieved that their doctors have already planned alternative treatments during supply interruptions. They notice that the transition between different medicines happens smoothly without delaying the child's chemotherapy schedule.

What is the role of surgery vs. chemotherapy in the Turkish Wilms tumor protocol?

In Turkey, specialists use the SIOP-based TPOG protocol, which prioritizes chemotherapy before surgery for children with Wilms tumor. This approach focuses on shrinking the tumor first to prevent rupture during its removal, leading to safer surgical results and better preservation of healthy kidney tissue.

Initial treatment. Doctors typically start with four weeks of chemotherapy to reduce the tumor's size.
Surgical timing. Surgeons like Dr. Ahmet Nadir Tosyali perform radical nephrectomies after the induction phase.
Bilateral cases. For tumors in both kidneys, chemotherapy may continue for 120+ days before surgery.
Adjuvant phase. Post-surgery chemotherapy is tailored based on the tumor's stage and specific cell histology.

Bookimed Expert Insight: Turkish oncology centers often use an integrated model where a single specialist holds dual qualifications in both pediatric surgery and oncology. Specialists like Dr. Ahmet Nadir Tosyali at Anadolu Medical Center provide this coordinated care, which simplifies the transition between the 4-week chemotherapy phase and the subsequent surgical intervention.

Patient Consensus: Parents often notice that the initial chemotherapy helps their children feel better before the major surgery. They frequently mention feeling reassured by specialists who explain how shrinking the tumor first makes the operation less complex.

What multidisciplinary follow-up care is available in Turkey for Wilms tumor patients?

Turkey provides multidisciplinary follow-up care through coordinated teams of pediatric oncologists, surgeons, and radiologists. Specialists like Dr. Hilmi Apak and Dr. Ahmet Nadir Tosyali manage long-term surveillance, focusing on kidney function, heart health, and early detection of recurrence using advanced imaging and blood analysis.

Oncology leadership. Specialists like Dr. Hilmi Apak lead tailored surveillance schedules and chemotherapy monitoring.
Surgical monitoring. Dr. Ahmet Nadir Tosyali tracks recovery and checks for potential abdominal complications.
Academic expertise. Dr. Metin Demirkaya provides university-level care standards for complex pediatric cancer tracking.
Specialized diagnostics. Follow-up includes quarterly ultrasounds, chest X-rays, and blood tests to ensure remission.

Bookimed Expert Insight: Patients benefit from dual-specialist expertise in Turkish centers. For example, some specialists are certified in both pediatric surgery and oncology. This combination allows one doctor to manage surgical recovery while simultaneously monitoring chemotherapy side effects. This reduces the need for separate appointments and improves care continuity.

Patient Consensus: Families value coordinated tumor boards that combine insights from oncologists and pediatric surgeons. Many recommend university hospitals where urolygists and cardiologists assist in monitoring kidney and heart health long-term.

I migliori medici per il trattamento di Tumore di Wilms (Nefroblastoma) a Ankara - TOP-1 medici

Richiedi preventivi da 3 migliori specialisti di in Turchia